The current POLB market cap is 68M. The company's latest EPS is GBP -0.0094 and P/E is -14.47.
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 |
Operating Income | -2.27M | -4.95M |
Net Income | -2.34M | -4.69M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Total Assets | 23.02M | 19.29M |
Total Liabilities | 438k | 966k |
Total Equity | 22.58M | 18.32M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
GBP (£) | GBP (£) | |
Operating | -2.15M | -4.37M |
Investing | -81k | -388k |
Financing | 23.18M | N/A |
Market Cap | 68M |
Price to Earnings Ratio | -14.47 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.2 |
Price to Book Ratio | 3.71 |
Dividend Yield | - |
Shares Outstanding | 500M |
Average Volume (1 week) | 700.05k |
Average Volume (1 Month) | 1.49M |
52 Week Change | 67.90% |
52 Week High | 15.70 |
52 Week Low | 6.55 |
Spread (Intraday) | 0.2 (1.46%) |
Company Name | Poolbeg Pharma Plc |
Address |
queen mary bioenterprises innovation centre london E1 2AX |
Website | https://www.poolbegpharma.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.